Cat. No. Name Size Price Add Cart
KI0696Glyburide50 mg$155.2

Chemical Characteristic

Product NameGlyburide
SynonymsGlibenclamide
CAS No.10238-21-8
Molecular Weight 494
FormulaC23H28ClN3O5S
Chemical Structure

Biological activities

Glyburide is an ATP-dependent K+ channel (Kir6, KATP) and cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel blocker. The IC50 value of glyburide against KATP channel is 3.0 nM.[1] Glyburide inhibits recombinant CFTR Cl- channels with an IC50 of 20 µM.[2] In vitro, glyburide inhibits the stimulation by cromakalim and diazoxide of 86Rb+ efflux from the portal vein and aorta with an IC50 of approximately 0.1 µM.[3] In freshly isolated rat islets, maximally effective concentrations of glyburide in stimulating insulin secretion in the presence of 15 mM glucose is 10 µM. At 5 nM glucose, glyburide also increases insulin secretion. Relative to the vehicle control group, glyburide administation (1 mg/kg orally) induces a sustained 2.4- and 1.7-fold increase in plasma insulin concentration in fasted and fed rats, respectively. Glyburide administation (1 mg/kg orally) also induces a 50% decrease in plasma glucose in both fasted and fed rats in vivo.[4] In isolated guinea pig hearts, 1 µM glyburide reduces reactive hyperemia with a peak flow reduction of 30.7% and debt repayment reduction of 78.0%, relative to vehicle-treated hearts. Besides, glyburide treatment (3 mg/kg) also inhibits both the peak flow and the percentage of debt repayment of reactive hyperemia in dogs.[5]

Protocols

In vivo: Glyburide is dissolved in 100% PEG 400 with heat in a water bath for 10 minutes.[5]

References

[1] Mukai E, et al. Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells. Am J Physiol. 1998, 274(1 Pt 1): E38-44.
[2] Sheppard DN, et al. Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol. 1992, 100(4): 573-591.
[3] Quast U, et al. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. J Pharmacol Exp Ther. 1989, 250(1): 261-271. 閵嗏偓閵嗏偓
[4] Hargrove DM, et al. Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo. Metabolism. 1996, 45(3): 404-409. 閵嗏偓閵嗏偓
[5] Clayton FC, et al. Coronary reactive hyperemia and adenosine-induced vasodilation are mediated partially by a glyburide-sensitive mechanism. Pharmacology. 1992, 44(2): 92-100. 閵嗏偓閵嗏偓

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.